Simplex Trading, LLC Enanta Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 221 shares of ENTA stock, worth $2,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221
Previous 1,269 82.58%
Holding current value
$2,064
Previous $16,000 87.5%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$10.05 - $16.54 $10,532 - $17,333
-1,048 Reduced 82.58%
221 $2,000
Q2 2024

Jul 25, 2024
BUY
$11.43 - $17.02 $4,343 - $6,467
380 Added 42.74%
1,269 $16,000
Q1 2024

Apr 25, 2024
BUY
$10.08 - $17.46 $1,512 - $2,619
150 Added 20.3%
889 $15,000
Q4 2023

Feb 02, 2024
BUY
$8.18 - $10.78 $6,045 - $7,966
739 New
739 $6,000
Q2 2023

Aug 04, 2023
SELL
$20.68 - $39.85 $1,282 - $2,470
-62 Reduced 24.8%
188 $4,000
Q4 2022

Feb 02, 2023
BUY
$40.77 - $53.73 $10,192 - $13,432
250 New
250 $11,000
Q1 2022

May 02, 2022
SELL
$56.06 - $74.11 $136,113 - $179,939
-2,428 Closed
0 $0
Q4 2021

Feb 23, 2022
BUY
$60.19 - $97.37 $146,141 - $236,414
2,428 New
2,428 $181,000
Q3 2020

Oct 14, 2020
SELL
$43.36 - $53.53 $3,035 - $3,747
-70 Closed
0 $0
Q2 2020

Jul 13, 2020
SELL
$46.37 - $57.58 $17,203 - $21,362
-371 Reduced 84.13%
70 $3,000
Q1 2020

Apr 29, 2020
BUY
$40.22 - $62.0 $17,737 - $27,342
441 New
441 $22,000
Q4 2019

Feb 05, 2020
SELL
$57.95 - $66.61 $51,749 - $59,482
-893 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$60.08 - $88.17 $53,651 - $78,735
893 New
893 $53,000
Q1 2019

Apr 18, 2019
SELL
$69.08 - $105.66 $21,829 - $33,388
-316 Closed
0 $0
Q4 2018

Jan 16, 2019
BUY
$65.41 - $84.65 $20,669 - $26,749
316 New
316 $22,000
Q3 2018

Oct 23, 2018
SELL
$85.46 - $126.37 $375,169 - $554,764
-4,390 Closed
0 $0
Q2 2018

Jul 30, 2018
BUY
$81.85 - $120.51 $359,321 - $529,038
4,390 New
4,390 $508,000
Q1 2018

Apr 26, 2018
SELL
$57.91 - $92.15 $326,844 - $520,094
-5,644 Closed
0 $0
Q4 2017

Jan 10, 2018
BUY
$45.65 - $59.37 $257,648 - $335,084
5,644
5,644 $331,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email